Development

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Articles

Engineering nanoparticles with optimal properties for use in cancer therapies.

Nanoparticles: Facilitating Targeted Drug Delivery in Cancer Therapy

The author discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.

Optimizing Drug Delivery for Modern Biologics

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Nanotechnology often is associated with parenteral drug delivery, particularly for anticancer therapies, but it also has applications in oral drug delivery

Exploring Nanotechnology in Drug Delivery

Pramote Cholayudth previously was the managing director of the Professional Conference Center, Ltd. He currently is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM consult, cpramote2000@yahoo.com.

To meet the requirements of the USP ?755? Minimum Fill and ?698? Deliverable Volume tests, target fill levels greater than 100% must be established. This article proposes a criterion for establishing an appropriate target fill level such that a sample will have a 95% probability of passing these USP tests at 95% confidence.

Establishing Target Fills for Semisolid and Liquid Dosage Forms

Gert W. Bos is an assistant in business development at OctoPlus BV, Zernikedreef 12, 2333 CL Leiden, The Netherlands.

Two types of hydrogels used in parenteral protein-delivery systems offer opportunities for achieving a variety of prolonged- and delayed-release patterns.

Formulation and Drug Delivery, Liquids